Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Celgene strengthens I&I portfolio with $7.2bn Receptos acquisition US-based biotechnology firm Celgene has expanded its inflammation and immunology (I&I) portfolio with the acquisition of Receptos for around $7.2bn. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News

Process & Production

Horizon Pharma gets USPTO issuance of additional notice of allowance with claims covering Pennsaid 2%
Horizon Pharma received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for US patent application number 14/705,636 (US publication number 2015-0231263), entitled 'Diclofenac Topical Formulation' that covers Horizon's US approved product PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%).
Production & Manufacturing > Process & Production > News
FDA approves Boehringer and Lilly's Synjardy to treat type 2 diabetes in adults
By PBR Staff Writer
Boehringer Ingelheim Pharmaceuticals (BIPI) and Eli Lilly and Company have received approval from the US Food and Drug Administration (FDA) for their Synjardy (empagliflozin and metformin hydrochloride) tablets to treat adults with type 2 diabetes (T2D).
Production & Manufacturing > Process & Production > News

OTC

Culturelle debuts only triple-action immune boosting supplement to include probiotics
A leading immune health probiotic brand is bringing new innovation to the cough/cold aisle this month. Culturelle Advanced Immune Defense is the first supplement with a triple action immune boosting formula strengthened by probiotics. The product is now available on shelves at drug, grocery and mass retailers nationwide.
Production & Manufacturing > OTC > News
Allergan recalls specific lots of REFRESH Lacri-Lube, REFRESH P.M. 3.5g, FML 0.1%, and Blephamide in US
Allergan announced that it is conducting a voluntary recall down to consumer level of specific lots of its REFRESH Lacri-Lube 3.5g and 7g for dry eye, REFRESH P.M. 3.5g for dry eye, FML (fluorometholone ophthalmic ointment) 0.1% (sterile ophthalmic ointment topical anti-inflammatory agent for ophthalmic use, 3.5g), and Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile topical ophthalmic ointment combining an antibacterial and a corticosteroid, 3.5g.
Production & Manufacturing > OTC > News

Manufacturing

Sucampo launches tender to buy R-Tech Ueno for $278m
By PBR Staff Writer
US-based Sucampo Pharmaceuticals has launched an all-cash tender offer through its Japanese subsidiary to acquire Japan-based pharmaceutical company R-Tech Ueno for around JPY33bn ($278m).
Production & Manufacturing > Manufacturing > News
Celgene strengthens I&I portfolio with $7.2bn Receptos acquisition
By PBR Staff Writer
US-based biotechnology firm Celgene has expanded its inflammation and immunology (I&I) portfolio with the acquisition of Receptos for around $7.2bn.
Production & Manufacturing > Manufacturing > News